脾切除治疗特发性血小板减少性紫癜
作者:
通讯作者:
作者单位:

作者简介:

朱功兵

基金项目:


Splenectomy for idiopathic thrombocytopenic purpura
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    目的总结脾切除对内科治疗无效或反复复发的特发性血小板减少性紫癜(ITP)的治疗效果。方法对近20年间经内科治疗无效的58例ITP患者行脾切除手术治疗,观察其临床疗效。52例术后随访6个月至12年,其中随访1年以上者48例。 结果术后2周内血小板恢复正常(≥100×109/L)者47例,占81.03%(47/58)。术后2个月随访,总有效率79.31%(46/58)。术后52例均获随访6个月,总有效率为78.85%(41/52),11例复发。结论对内科治疗无效或复发性ITP,脾切除治疗有效。术前对激素治疗暂时有效、术后血小板回升较早及回升幅度较高者预后较好。

    Abstract:

    ObjectiveTo study the results of splenectomy for patients with idiopathic thrombocytopenic purpura(ITP), which refractory to medical therapy or with repeat recurrence of symptoms. Methods58 ITP patients who failed to respond to conservative management were treated with splenectomy and the clinical outcome was observed. Postoperatively, 52 cases were followed up for 6 months to 12 years, and in 48 of these cases the followup was more than 1 year. ResultsPlatelet count recovered to normal(≥100×109/L ) two weeks after operation in 47 cases(81.03%). The total effective rate was 79.31% when followedup for 2 months, 78.85% when followedup for 6 months and 11 cases had recurrence. ConclusionsSplenectomy is a safe and effective therapy for patients with ITP who failed to respond to conservative management or have relapse of ITP. Patients who showed temporary response to preoperative steroid therapy and those who had an early or a high amplitude of increase of platelet count after operation have better prognosis.

    参考文献
    相似文献
    引证文献
引用本文

朱功兵,陈启龙.脾切除治疗特发性血小板减少性紫癜[J].中国普通外科杂志,2005,14(8):13-.
DOI:10.7659/j. issn.1005-6947.2005.08.013

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2005-08-25